what does the checkmate-331 trial of nivolumab vs. chemo for relapsed sclc tell us? (bmic-072)
Published 5 years ago • 228 plays • Length 8:58Download video MP4
Download video MP3
Similar videos
-
1:32
dr. spigel on checkmate-331 trial for sclc
-
6:04
checkmate 816 trial: nivolumab platinum-doublet chemotherapy vs chemo as neoadjuvant treatment...
-
13:07
nivo/ipi vs. chemo: key results from checkmate 227 (bmic-034)
-
5:51
nsclc: use of tmb in checkmate-227
-
2:33
checkmate 227: chemo-free nsclc treatment
-
9:40
are tmb and nivolumab/ipilimumab ready for clinical use? insights from checkmate 227 (bmic-035)
-
5:51
checkmate-227 and the role of tmb in nsclc
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
6:07
interpreting the results of checkmate-227 in nsclc
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
2:17
dr. borghaei on the checkmate-227 trial in nsclc
-
11:30
asco 2021 lung recap: surgical outcomes & checkmate 816: nivolumab in early stage nsclc
-
1:24
checkmate 77t: perioperative nivolumab in nsclc - onctalk lung 2023
-
2:01
checkmate 172 trial of nivolumab for advanced melanoma: preliminary results
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
5:25
dual checkpoint inhibition in nsclc: checkmate-227
-
5:31
checkmate-227: nivolumab ipilimumab in mnsclc
-
2:08
dr. bunn on missed endpoint in checkmate-026 for nsclc
-
7:23
surgical outcomes from checkmate 816: nivo plus chemo vs chemo alone as neoadjuvant treatment fo...